Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-25-003594
Filing Date
2025-05-15
Accepted
2025-05-15 07:54:10
Documents
70
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR MAR 2025 aclarion_i10q-033125.htm   iXBRL 10-Q 1039782
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER aclarion_ex3101.htm EX-31.1 10326
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER aclarion_ex3102.htm EX-31.2 10542
4 CERTIFICATION aclarion_ex3201.htm EX-32.1 3742
5 CERTIFICATION aclarion_ex3202.htm EX-32.2 3763
  Complete submission text file 0001683168-25-003594.txt   5491901

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE acon-20250331.xsd EX-101.SCH 54661
7 XBRL CALCULATION FILE acon-20250331_cal.xml EX-101.CAL 49772
8 XBRL DEFINITION FILE acon-20250331_def.xml EX-101.DEF 223386
9 XBRL LABEL FILE acon-20250331_lab.xml EX-101.LAB 328179
10 XBRL PRESENTATION FILE acon-20250331_pre.xml EX-101.PRE 288162
73 EXTRACTED XBRL INSTANCE DOCUMENT aclarion_i10q-033125_htm.xml XML 744363
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41358 | Film No.: 25948767
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)